Skip to content

Sensititre CMC4ANYF

by Trek Diagnostic Systems, Inc.

Sensititre CMC4ANYF is a medical device (FDA Class II; FDA product code JWY, Manual Antimicrobial Susceptibility Test Systems) made by Trek Diagnostic Systems, Inc., cleared under FDA 510(k) K060621 on 21 Apr 2006 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI M578CMC4ANYF2), active as of 23 Oct 2026. 9 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

9 closed

Documents

510(k) K060621

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberM578CMC4ANYF2 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK060621 Date21 Apr 2006DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K060621 decided 21 Apr 2006 Active
  • FDA GUDID UDI-DI M578CMC4ANYF2 listed 24 Sep 2016 Listed

Recalls

9 recalls · FDA

  • 9 recalls, same reason

    • Terminated Z-0329-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0332-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0331-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0333-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0327-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0328-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0334-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0335-2023 FDA Class I initiated 20 Oct 2022
    • Terminated Z-0330-2023 FDA Class I initiated 20 Oct 2022

    An internal technical investigation has confirmed that Thermo Scientific" Gram Negative IVD AST Sensititre Plate may lead to false susceptible results for Proteae Tribe (including Proteus spp., Providencia spp., Morganella Morganii) when tested with doripenem, ertapenem, meropenem, imipenem, cefepime, piperacillin/tazobactam and aztreonam.

Timeline

11 dated events

  1. Listed FDA GUDID M578CMC4ANYF2
  2. Recall initiated FDA recalls Z-0329-2023
  3. Recall initiated FDA recalls Z-0332-2023
  4. Recall initiated FDA recalls Z-0331-2023
  5. Recall initiated FDA recalls Z-0333-2023
  6. Recall initiated FDA recalls Z-0327-2023
  7. Recall initiated FDA recalls Z-0328-2023
  8. Recall initiated FDA recalls Z-0334-2023
  9. Recall initiated FDA recalls Z-0335-2023
  10. Recall initiated FDA recalls Z-0330-2023

1 earlier event are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Sensititre
Generic name
Bacterial species culture isolate identification/antimicrobial susceptibility profile IVD, kit
Model / reference
CMC4ANYF
Primary DI / UDI-DI
M578CMC4ANYF2
510(k) Number
FDA product code
JWY
GMDN term
Bacterial species culture isolate identification/antimicrobial susceptibility profile IVD, kit
Device class
Class II
Regulation number
866.1640
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code JWY (Manual Antimicrobial Susceptibility Test Systems).

Other devices from Trek Diagnostic Systems, Inc.

  • STP8F

    Class II
  • CMC1NJNF

    Class II
  • Sensititre Vizion

    Class II
  • Sensititre CMC3VGNF

    Class II

See all devices from Trek Diagnostic Systems, Inc. →

Properties

  • Single use
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)